Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027

Blood Transfusion Diagnostics Market Scenario:

Blood Transfusion Diagnostics Market Size is expected to reach USD 2.45 billion in 2023 from USD 1.50 billion in 2016 with a CAGR of approximately 8.2% during the forecast period 2017-2023.

Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff. Rising prevalence of infectious diseases, increasing in number of blood transfusion procedures, demand for screened blood products and increasing campaigning or awareness programs drive the growth of this market. Demand of blood and blood products exceeds over their supply thus contributing to the growth of this market. 

Study objectives: Main objective of this research is to provide information about Blood Transfusion Diagnostics market, product, technology and end users.

• To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the Blood Transfusion Diagnostics market.


• To provide insights about factors affecting the market growth.


• To analyze the Blood Transfusion Diagnostics market based on various factors- Price Analysis, Supply Chain Analysis, Porters’ Five Force Analysis etc.


• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies - Americas, Europe, Asia Pacific and Middle East & Africa and their countries.


• To provide country level analysis of the market with respect to the current market size and future prospective.


• To provide country level analysis of the market for segments by product, by technology, by end and its sub-segments.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the Blood Transfusion Diagnostics Market.


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Blood Transfusion Diagnostics market.

Intended Audience

• Medical device manufactures


• Medical devices suppliers


• Contract Research Organizations (CROs)


• Research and Development (R&D) Companies


• Academic Medical Institutes and Universities

Figure 1: Blood Transfusion Diagnostics market, by technology, 2016:

 

Source: Press Release, Company presentation, annual reports

Segmentation:

Blood Transfusion Diagnostics market has been segmented on the basis of blood product including Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations and other products. On the basis of technology, the market is segmented into Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test and other technologies. ELISA is further segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). Nucleic Acid Amplification is segmented into Thermomechanical analysis (TMA) and real-time PCR. End users are hospitals, clinics, blood banks, laboratories.

Regional Analysis:

Globally, Blood Transfusion Diagnostics market consists of four regions Americas, Europe, Asia Pacific and Middle East and Africa. America is the largest market whose growth is attributed to an increase in the use of nucleic acid amplification test and large number of awareness programs conducted by the government bodies and non-government organizations. Europe is the second largest market. Asia Pacific is showing positive growth this market. The market shows steady growth in Middle East & Africa.

Figure 2: Market Synopsis

Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview.

Key Players

Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Immucor (U.S),  Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).

The report for Blood Transfusion Diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

 

Frequently Asked Questions (FAQ) :

---